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SUMMARY
Research background. Antioxidants are important compounds present at low concen-
trations that inhibit oxidation processes. Due to the side effects of synthetic antioxidants, 
research interest has increased considerably towards finding natural sources of antioxi-
dants that can replace the synthetic ones. The emergence and spread of antibiotic resist-
ance require the development of new drugs or some potential sources of novel medicine. 
This work aims to extract the secondary metabolites of Saccharomyces cerevisiae using 
ethyl acetate as a solvent and to determine the antioxidant and antimicrobial activities of 
these extracted metabolites.
Experimental approach. The antioxidant activity of the secondary metabolites of S. cer-
evisiae were determined using DPPH, ABTS and FRAP assays. Furthermore, the antimicro-
bial potential of the ethyl acetate extract of S. cerevisiae against Cutibacterium acnes, Staph-
ylococcus aureus and Staphylococcus epidermidis was assessed.
Results and conclusion. Five out of 13 of the extracted secondary metabolites were 
identified as antioxidants. The antioxidant activity of the S. cerevisiae extract exhibited 
relatively high IC50 of 455.26 and 294.51 μg/mL for DPPH and ABTS respectively, while the 
obtained FRAP value, expressed as ascorbic acid equivalents, was 44.40 μg/mL. Moreover, 
the extract had a significant antibacterial activity (p<0.05) against Staphylococcus aureus 
and Staphylococcus epidermidis at the concentrations of 100 and 200 mg/mL, respectively. 
However, no inhibitory effect was observed against Cutibacterium acnes as the extract was 
only effective against the bacterium at the concentrations of 300 and 400 mg/mL (inhibi-
tion zones ranging from 9.0±0.0 to 9.3±0.6) respectively (p<0.05). Staphylococcus aureus 
was highly sensitive to the extract, with a MIC value of 18.75 mg/mL. 
Novelty and scientific contribution. This report confirmed the efficacy of the secondary 
metabolites of S. cerevisiae as a natural source of antioxidants and antimicrobials and sug-
gested the possibility of employing them in drugs for the treatment of infectious diseases 
caused by the tested microorganisms. 
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INTRODUCTION
Saccharomyces cerevisiae is a eukaryotic microbe that belongs to the Saccharomycoti-
na family. Yeasts, including S. cerevisiae, possess the ability to produce antimicrobial and 
antifungal compounds that inhibit the growth of pathogenic bacteria and fungi (1). It pro-
duces toxic proteins or glycoproteins to combat other strains of yeast or bacteria (2). Ac-
cording to Hassan (3), glutathione (GSH), sulfur-containing amino acids and Maillard reac-
tion products are the components that contribute to the antioxidative properties of S. 
cerevisiae. GSH is the most abundant thiol in yeast cells that plays a considerable role in 
antiradical activity (4). Besides that, Meng et al. (5) reported that GSH and ascorbic acid 
can act as radical scavengers in S. cerevisiae. Ascorbic acid is a small water-soluble mole-
cule that works with GSH to form a redox couple (6). GSH is described as a cofactor of ox-
idative stress enzymes that can modulate enzyme activity to maintain redox balance (4).
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In recent years, natural antioxidants are becoming more 
likely to serve as alternatives to synthetic antioxidants prob-
ably due to the associated side effects of the synthetic anti-
oxidants, such as their carcinogenicity and toxicity. Thus, 
there has been much interest in finding safer and more effec-
tive natural antioxidant sources (7). Secondary metabolites of 
S. cerevisiae have attracted more attention as a potential 
source of natural antioxidants owing to their strong bioactive 
properties in the human body (8). The use of S. cerevisiae as a 
safe source of ingredients and additives in food processing 
has been widely accepted by the consumers (9). Perhaps 
these secondary metabolites of S. cerevisiae can act as natural 
antioxidants; therefore, it is crucial to evaluate their antioxi-
dant activity for potential application in the food and phar-
maceutical industries. 
To date, there are only a few yeast strains that can be re-
ferred to as producers of secondary metabolites with antiox-
idant properties. Cutibacterium acnes, a Gram-positive anaer-
obic bacterium, is believed to be the main causative agent of 
acne. Furthermore, Staphylococcus epidermidis and Staphylo-
coccus aureus have been reported as the causative agents of 
acne vulgaris and have been isolated in 53 and 41 % aerobic 
cultures of pustular and nodulocystic skin lesions, respective-
ly (10). Different acne treatments include lifestyle remedies, 
topical medication, oral medication and medical procedures. 
However, patients may suffer from side effects from these 
treatments; hence, people nowadays prefer natural products 
as treatment options due to their body tolerance. This re-
search focuses on the extraction and identification of the 
secondary metabolites of S. cerevisiae. Different antioxidant 
assays , namely DPPH, ABTS and FRAP, were employed to de-
termine the antioxidant activity of the extracted metabolites. 
Finally, the antibacterial activity of the secondary metabolites 
of S. cerevisiae was investigated against Cutibacterium acnes, 
Staphylococcus aureus and Staphylococcus epidermidis. 
MATERIALS AND METHODS
Materials
Potato dextrose agar (PDA), ethyl acetate, methanol, 
ascorbic acid, potassium persulfate hydrochloric acid iron(III) 
chloride hexahydrate (FeCl3·6H2O), dimethylsulfoxide (DMSO), 
Mueller-Hinton agar (MHA), tryptic soy agar (TSA), sterile Mu-
eller-Hinton broth (MHB), and sterile tryptic soy broth (TSB) 
were purchased from Merck (Darmstadt, Germany). Potato 
dextrose broth (PDB) was obtained from CONDA (Madrid, 
Spain). DPPH solution, Tris(2-pyridyl)-s-triazine (TPTZ) and io-
donitrophenyltetrazolium violet were purchased from Sig-
ma-Aldrich, Merck (St Louis, MO, USA). ABTS powder was ob-
tained from Roche (Basel, Switzerland). 
Yeast cultivation
Potato dextrose agar (PDA) was prepared by dissolving 
39 g dehydrated medium in 1 L distilled water. The medium 
was stirred, heated and sterilized by autoclaving at 121 °C for 
15 min. The medium was then poured into agar plates and 
allowed to solidify. The yeast Saccharomyces cerevisiae was 
obtained from the laboratory unit of the Faculty of Industrial 
Sciences and Technology (FIST), Universiti Malaysia Pahang 
(UMP). The yeast was streaked on PDA with a sterile inoculat-
ing loop and incubated at 30 °C for 3 days. Potato dextrose 
broth (PDB) was prepared by dissolving 26.5 g dehydrated 
medium in 1 L distilled water. The medium was stirred, heat-
ed and autoclaved at 121 °C for 15 min. A single yeast colony 
was picked from the PDA and cultivated in the PDB, followed 
by incubation in an orbital shaking incubator (BD115; Binder, 
Tuttlingen, Germany) for 3 days at 25–30 °C with mild agita-
tion at 130 rpm. 
Extraction of secondary metabolites from yeast
The extraction was carried out according to the method 
described by Swathi et al. (11). Ethyl acetate was added as a 
solvent to the yeast liquid culture in 1:1 ratio. The mixture was 
shaken for 10 min in a separatory funnel for complete extrac-
tion of the secondary metabolites. Then, it was allowed to 
settle for a few minutes. Two layers of liquid were formed; the 
upper layer containing the metabolites was collected into Fal-
con tubes, while the bottom layer containing the yeast cells 
and PDB was washed thoroughly to ensure complete extrac-
tion of the metabolites before being discarded. The separat-
ed upper layer was centrifuged at 2900×g for 5 min (centri-
fuge Rotofix 32; Hettich, Schwerin, Germany) to remove any 
suspended yeast cells and medium contaminants. The result-
ing supernatant was collected and evaporated to dryness at 
35–40 °C using an RV 10 digital rotary evaporator (N-1200A; 
Evela, Shanghai, PR China). A green-coloured extract was ob-
tained after the drying and stored for further use.  
Analysis of secondary metabolites of yeast using GC-MS
The crude extract was diluted in gas chromatography 
(GC) grade ethyl acetate before GC-MS analysis. The analysis 
was conducted using a GC-MS 6890A system (Agilent, Santa 
Clara, CA, USA). A volume of 1 μL of the sample was intro-
duced into the heated injector tube using a microliter volume 
syringe. The vapourised sample was carried through the SGE 
BPX5 GC column by helium gas at the rate of 1.0 mL/min. The 
components in the sample were separated and a gas chro-
matogram was obtained. Then, the effluent of the GC column 
was introduced directly into the mass spectrometer via a 
transfer line at 320 °C. The gas molecules were converted into 
ions at an ion source temperature of 230 °C using electron 
energy of 70 eV. The scan range was set at 45–500 Da. The 
ions were detected by a detector and the information was 
sent to the computer. The components were identified based 
on their retention indices and by comparison of their mass 
spectra with the available data in the existing GC-MS library 
(NIST/NIH/EPA mass spectral library) (12). 
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Determination of antioxidant activity
DPPH assay
DPPH assay was conducted according to the suggested 
method by Hassan (3) with some modifications. DPPH solu-
tion (0.1 mM) was first prepared in absolute methanol and 
added into different tubes at 1 mL volumes. Then, 1.0 mL 
yeast extract was added into each tube at different concen-
trations (125–2000 μg/mL) and mixed well. A set of blanks was 
prepared by adding 1.0 mL methanol with 1.0 mL yeast ex-
tract at different concentrations. All the mixtures were incu-
bated in the dark at room temperature for 30 min. Negative 
control was prepared by the same procedure without the 
yeast extract. Ascorbic acid solution was used as a positive 
control. The absorbance of the resulting mixtures was meas-
ured at 517 nm using a 10S UV-Vis spectrophotometer 
(Genesys, Daly City, CA, USA). The measurements were taken 
in triplicate and the mean values were calculated. 
ABTS assay
The ABTS assay was carried out based on the method pro-
posed by Hameed et al. (13) with some modifications. The 
stock solution was prepared by reacting the 7.00 mM ABTS 
solution with 2.45 mM potassium persulfate at the ratio of 1:1 
(V/V), and kept in the dark at room temperature for 12–16 h 
before use (to generate ABTS +̇). The ABTS +̇ solution was di-
luted with absolute methanol and adjusted to the absorb-
ance from 0.7 to 0.75 at 734 nm. A volume of 200 µL of the 
yeast extract at different concentrations (15.63–2000 µg/mL) 
and 1.8 mL ABTS +̇ solution were mixed well in the tubes and 
incubated in the dark at room temperature for 30 min. Neg-
ative control was prepared according to the same procedure 
without the yeast extract. Ascorbic acid solution was used as 
a positive control. The absorbance was measured at 734 nm 
using Infinite 200 PRO microplate reader (Tecan, Männedorf, 
Switzerland). The measurements were taken in triplicate and 
the mean values were calculated. 
FRAP assay
The FRAP reagent was prepared by mixing 300 mM ace-
tate buffer at pH=3.6, 10 mM TPTZ in 40 mM hydrochloric acid 
(Merck), and 20 mM FeCl3·6H2O at the ratio 10:1:1. The mixture 
was incubated for 15 min at 37 °C before use. Ascorbic acid 
was used in distilled water at different concentrations (200–
1000 μg/mL) as the positive control to generate a standard 
curve. A volume of 150 μL of the yeast extract (in ethyl ace-
tate) or standard was mixed thoroughly with 2.85 mL FRAP 
reagent in Falcon tubes. The formation of an intense blue col-
our complex suggests the reduction of Fe3+ to Fe2+ in TPTZ 
complex. The mixture was incubated in the dark for 30 min. 
The absorbance (A) of the solution was measured at 593 nm 
using the Infinite 200 PRO microplate reader (Tecan). The 
measurements were taken in triplicate and the mean values 
were calculated. 
Evaluation of antibacterial activity of yeast  
secondary metabolites 
Kirby-Bauer disc diffusion susceptibility test
In this test, the yeast extract sample was used against 
Cutibacterium acnes (ATCC 6919), Staphylococcus aureus (ATCC 
6538) and Staphylococcus epidermidis (ATCC 12228). The con-
centrations of the yeast secondary metabolites were 100, 200, 
300 and 400 mg/mL. The extract was dissolved in DMSO. Gen-
tamycin discs (Thermo Scientific™ Oxoid™) with 10 µg drug 
acted as the positive control, while the disc with DMSO sol-
vent but without any extract acted as the negative control. A 
volume of 7 µL of the dissolved extract and solvent was im-
pregnated into sterile discs and dried in the laminar flow 
hood (model AHC-4DI; ESCO, Selangor, Malaysia) to remove 
the solvent completely. The antimicrobial tests against S. au-
reus and S. epidermidis were carried out in MHA, while the disc 
diffusion test against C. acnes was carried out on TSA as C. 
acnes cannot grow on MHA. The three tested bacterial strains 
were cultured in broth and the concentration of the bacteria 
was adjusted to 0.5 McFarland standard. According to Clinical 
and Laboratory Standards Institute (CLSI), 0.5 McFarland 
standard is equivalent to an absorbance value range from 
0.08 to 0.13 at 625 nm. The TSA plates with C. acnes were in-
cubated in the anaerobic jar at 37 °C for 48–72 h, while the 
MHA plates were incubated in the presence of oxygen at 
37 °C for 8–16 h. The formed inhibition zones were observed 
after every 6 h of incubation; the diameter of the zones was 
measured in mm. This test was performed in triplicate. 
Determination of minimum inhibitory concentration 
The minimum inhibitory concentration (MIC) of the ex-
tracts was determined in a 96-round bottom well microplate. 
The initial concentration of the secondary metabolites of S. 
cerevisiae used for the MIC determination was the lowest con-
centration that formed an inhibition zone in the disc diffusion 
method for the three bacterial strains. Two-fold serial dilution 
was carried out to make a total of eight different concentra-
tions of the extract. Sterile MHB was added to each well con-
taining S. aureus or S. epidermidis, while sterile TSB was added 
for C. acnes. The extract was prepared in 100 % DMSO at the 
concentration of 300 mg/µL, then 100 µL of the prepared ex-
tract were transferred to the first column of the well, mixed, 
and 100 µL of the mixture were also transferred to the next 
well in each row. Gentamicin was used as the positive control 
at the concentration of 1 mg/µL, while the negative control 
was the broth and solvent without any extract. The suspen-
sion of the three tested bacterial strains was adjusted to the 
concentration equivalent to 0.5 McFarland standard using a 
UV-Vis spectrophotometer (Genesys). A volume of 100 µL 
bacterial suspension was added into each well, then the mi-
croplate was covered, sealed, and incubated at 37 °C. The 
microplates containing S. aureus and S. epidermidis were then 
incubated for 6 h and those containing C. acnes 12 h. After the 
incubation period, 50 µL of 0.4 mg/mL p-iodonitrophen-
yltetrazolium violet indicator (Sigma-Aldrich, Merck) was 
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Table 1. Secondary metabolites identified in the ethyl acetate extract of S. cerevisiae
Compound Molecular formula tR/min Peak area/%
Benzeneethanol,4 hydroxy- C8H10O2 11.548 12.14
1-Methyl-3,3-diphenylurea C14H14N2O 13.796  1.26
1H-Indole-3-ethanol C10H11NO 15.505 10.68
Diethyldithiophosphinic acid C4H11PS2 16.082  2.09
9-Hexadecenoic acid C16H30O2 17.020  1.66
Diethyldithiophosphinic acid C4H11PS2 17.057  1.90
2-Hydroxy-3,5,5-trimethyl-cyclohex-2-enone C9H14O2 17.230  1.80
Hexadecanoic acid, butyl ester C20H40O2 19.133  1.15
Octadecanoic acid, butyl ester C22H44O2 20.852  0.69
Pyrrolo[1,2-a]pyrazine-1,4-dione,hexahydro-3-(phenylmethyl)- C14H16N2O2 21.444  3.74
1,2-Benzenedicarboxylic acid, mono(2-ethylhexyl) ester C16H22O4 22.152 58.33
2,3-Diphenyl-5,8-dimethoxy-6-acetamidoquinoxaline C24H21N3O3 23.117  1.21
l-Proline, N-allyloxycarbonyl-, undec-10-enyl ester C20H33NO4 24.579  3.35
added into each well and further incubated for 30 min. The 
colour change of each well was observed. The colour of the 
indicator turns pink when there is active bacterial growth in 
any well, while no colour change indicates no active bacteri-
al growth. The lowest concentration of the extract that inhib-
ited bacterial growth was recorded as the MIC. This assay was 
performed in triplicate. 
Statistical analysis
Statistical analysis of the obtained data was carried out 
using one way-ANOVA. The mean value and standard devia-
tion of the data were generated with the level of significance 
set at p<0.05.
RESULTS AND DISCUSSION 
Extraction of S. cerevisiae secondary 
metabolites and GC-MS analysis
The selection of a solvent for extraction depends on the 
nature of the desired bioactive compounds. Ethyl acetate, 
which was used as an extraction solvent in this study, has a 
medium polarity with a polarity index of 4.4. It has low toxic-
ity on the tested strains and mild effect on biological cells (14). 
When the liquid broth cultured with S. cerevisiae was mixed 
with 100 % ethyl acetate in the separatory funnel, two distinct 
layers formed as ethyl acetate is immiscible with water. Gen-
erally, organic compounds do dissolve in organic solvents. 
Ethyl acetate can even extract compounds from the aqueous 
layer. The GC-MS results were obtained by comparing the 
spectra and matching them against the library database 
(NIST/NIH/EPA mass spectral library (12)). Table 1 shows the 
secondary metabolites recognized in S. cerevisiae extract.
Fig. S1 shows the chromatogram of the extracted sec-
ondary metabolites from S. cerevisiae. Based on the results, 
the longest retention time of 24.58 min was recorded for 
l-proline, N-allyloxycarbonyl-, undec-10-enyl ester. The reten-
tion time of any compound depends on the different 
strengths of its interaction with the stationary phase. Thus, this 
compound had the strongest interaction with the stationary 
phase and required more time to migrate through the column. 
The 1,2-benzenedicarboxylic acid mono(2-ethylhexyl) ester 
had the highest concentration in the extract of S. cerevisiae with 
58.33 % of the total peak area. The GC-MS analysis of Saccharo-
myces cerevisiae has been reported to identify the presence of 
different compounds, such as thieno[2,3-c]furan-3-carbonitrile, 
2-amino-4,6-dihydro-4,4,6,6-, oxime-, methoxyphenylacetic 
acid, erythritol, 3-[3-bromophenyl]-7-chloro-3,4-dihydro -10-
hydroxy-1,9 (2H,10H), 2-methyl-9-β-d-ribofuranosylhypoxan-
thine, dodecane,1-chloro-, 2,7-diphenyl-1,6-dioxopyridazino 
[4,5:2’,3’] pyrrolo[4’,5’-d] pyridazine, and 2-bromotetradecano-
ic acid (15). 
Antioxidant activity 
DPPH radical scavenging activity
The DPPH radical scavenging activity of the S. cerevisiae 
extract was evaluated based on its ability to reduce DPPH free 
radicals, which decolourises purple DPPH solution (16). Fig. 1a 
shows the radical scavenging ability of the S. cerevisiae ex-
tract compared to ascorbic acid. The highest DPPH radical 
scavenging activity of ascorbic acid and the yeast extract was 
95.91 and 90.96 % at the concentrations of 250 and 2000 μg/
mL, respectively. Ascorbic acid exhibited a significantly high-
er DPPH radical scavenging activity than the S. cerevisiae ex-
tract. Ascorbic acid is one of the active reducing agents and 
scavengers of free radicals in biological systems, acting as a 
scavenger of free oxidizing radicals and harmful oxygen spe-
cies (17). Hassan (3) documented that 25 mg/mL baker’s yeast 
autolysate showed (69.06±1.22) % DPPH radical scavenging 
activity due to the reduction of the molarity of the DPPH solu-
tion from 0.2 to 0.1 mM. Moreover, the extraction method 
might affect the antioxidant capacity of an extract (18). The 
study by Sugiyama et al. (19) evaluated the antioxidant activ-
ity of indole derivatives from a marine sponge-derived yeast. 
All compounds showed weak activities in the DPPH assay. 
The extract of S. cerevisiae has been reported to exhibit the 
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highest DPPH radical scavenging activity due to its high tryp-
tophol content from alcoholic fermentation (20). Ethanolic 
extracts of Hibiscus sabdariffa and Croton caudatus leaves 
have been evaluated for free radical scavenging activity in 
the model system of S. cerevisiae. H. sabdariffa and C. cauda-
tus at a concentration of 500 μg/mL demonstrated an im-
mense free radical scavenging capacity of DPPH with an IC50 
value of 184.88 and 305.39 μg/mL, respectively (21). Further-
more, it has been demonstrated that soybean with Tricholo-
ma matsutake and S. cerevisiae showed considerable DPPH 
radical scavenging activity (22). 
ABTS radical scavenging activity
The ABTS radical scavenging activity of the S. cerevisiae 
extract was assessed based on its ability to reduce ABTS rad-
ical cation. The ABTS +̇ was produced from the oxidation of 
ABTS with potassium persulfate, which involves the loss of an 
electron from the nitrogen atom of ABTS (23). The ABTS +̇ 
solution is bluish-green in methanol. Its absorbance was de-
termined at 734 nm to minimize the interference from other 
absorbing components and sample turbidity. Fig. 1b shows 
the relative ability of the S. cerevisiae extract to scavenge 
ABTS +̇ compared to that of ascorbic acid. The standard ascor-
bic acid and yeast extract at the concentration of 2000 μg/mL 
recorded the highest inhibition values of 99.17 and 92.20 % 
respectively. This result indicated that both ascorbic acid and 
yeast extract effectively inhibited the formation of ABTS +̇. It 
has been reported that endophytic yeasts isolated from the 
lower stem and roots of Phragmites australis Cav showed 88 % 
radical scavenging activity in the ABTS assay (24). Further-
more, Aspergillus awamori DT11 exhibited ABTS +̇ scavenging 
activity of 34.07 % compared to ascorbic acid (44.5 %), which 
was used as a positive control (25). 
Results of FRAP assay 
The FRAP of S. cerevisiae extract was evaluated based on 
the ability to reduce iron(III) to iron(II)) via electron donation 
to the sample. This reduction was monitored by measuring 
the change in the absorbance at 593 nm. The assay was con-
ducted at low pH values (pH=3.6) to maintain iron solubility 
and electron transfer (26). Table 2 shows the FRAP values of 
each yeast extract at different concentrations. In general, the 
absorbance readings increased when the concentration of 
ascorbic acid and yeast extract increased from 200 to 1000 
μg/mL. This was due to the reduction of the Fe3+ in TPTZ com-
plex to the intensely blue-coloured Fe2+ (26). The standard 
solution of ascorbic acid and yeast extract recorded the high-
est absorbance of 3.6291 and 0.1611 respectively, at the con-
centration of 1000 μg/mL. The yeast extract exhibited the 
highest FRAP value expressed as ascorbic acid equivalents of 
44.40 μg/mL, indicating that S. cerevisiae can act as a potent 
antioxidant to reduce Fe3+ ion. Trolox, a water-soluble vitamin 
E analogue, was used as a reference standard to determine 
the antioxidant capacity of yeast microcarriers. The Trolox 
equivalent values for yeast cell wall particles and native yeast 
were reported to be 0.20 and 7.48 μM, respectively (27). Chen 
et al. (28) reported that Lactobacillus rhamnosus and Saccha-
romyces cerevisiae significantly improved FRAP in comparison 
to their non-fermented counterparts, and both activities 
were attributed to the released phenolics during the sol-
id-state fermentation.
Benzeneethanol, 4-hydroxy, known as tyrosol, showed 
antioxidant activity in vitro and was able to inhibit or slow 
down the oxidation reactions brought by dioxygen or perox-
ides in animal tissues (29). However, tyrosol with its deriva-
tives appeared to be less active than hydroxytyrosol and its 
analogues due to the influence of catechol structure (29). An-
tenucci et al. (30) reported that oligotyrosol exhibited higher 
antioxidant activity than tyrosol using DPPH, FRAP and 
hydro xyl radical scavenging assays. 1H-indole-3-ethanol is 
indol yl alcohol substituted with a 1H-indol-3-yl group. 

















































Fig. 1. Antioxidant assays: a) DPPH radical scavenging activity of stan-
dard ascorbic acid and Saccharomyces cerevisiae extract, and b) ABTS 
radical scavenging activity of ascorbic acid and S. cerevisiae extract
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1H-indole-3-ethanol plays a role as a metabolite of both 
plants and S. cerevisiae. Hexadecanoic acid is a fatty acid ester 
of plant and animal origins that acts as an insect repellent. 
Extracted from wild-growing mushrooms, it exhibited anti-
oxidant activity at the concentration of 0.10 mg/mL (31). It is 
one of the twenty bioactive compounds isolated from Thesi-
um humile Vahl with reported antioxidant activity (32). Gond-
wal et al. (33) reported that the water extract from the seeds 
and fruit pulp of Skimmia anquetilia can be used as a natural 
antioxidant due to its hexadecanoic acid content. Octadeca-
noic acid is a fatty acid ester and an algal metabolite that acts 
as a defoaming agent in processing beet sugar and yeast. 
Hexane extract of Sinapis alba exhibited slightly higher anti-
oxidant activity than the standard ascorbic acid in phospho-
molybdenum assay due to the existence of octadecanoic acid 
and other phytocomponents (34). Pyrrolo[1,2-a]pyrazine-1,4 -
-dione, hexahydro isolated from a marine bacterium Bacillus 
tequilensis MSI45 exhibited high antioxidant activity (35). The 
antioxidant activity of different pyrrolizidines, including 
pyrrolo[1,2-a]pyrazine-1,4-dione, and hexahydro-3-(phenyl-
methyl) in the ethyl acetate extract of Streptomyces omiyaen-
sis has been reported by Tangjitjaroenkun (36). Also, Strepto-
myces strain MUSC 149(T) showed a strong antioxidant 
activity due to its pyrrolo[1,2-a]pyrazine-1,4-dione, hexahy-
dro- content (37). 
Antimicrobial activity 
Disc diffusion method is a popular antimicrobial test in 
microbiology laboratories due to its simplicity and ability to 
test multiple antimicrobial agents (38). S. epidermidis and S. 
aureus can grow in a range of pH=4.0–9.8, with an optimum 
pH=6–7 (39). C. acnes showed optimal growth in the range 
from pH=6.0 to 7.0; however, it can grow in the range pH=5.0 
to 8.0 (39). The pH value of the dissolved extract ranged from 
6 to 7, which is considered suitable for bacterial growth. Four 
concentrations of the dissolved extract (100, 200, 300 and 400 
mg/mL) were used in this assay. The dry mass of the extract 
loaded onto sterile discs was 0.7, 1.4, 2.1 and 2.9 mg. The ob-
served antibacterial activity of the S. cerevisiae extract is 
shown in Table 3. The results revealed that S. cerevisiae extract 
effectively suppressed the growth of the tested bacteria at 
different potency levels. 
Among the tested bacteria, both S. aureus and S. epider-
midis were susceptible to 400 mg/mL S. cerevisiae extract. 
As  shown in Table 3, the most susceptible bacterium to 
400 mg/mL extract was S. aureus (11.5 mm), followed by S. 
epidermidis and C. acnes with mean inhibition zones of 
10.5 mm and 9.3, respectively. At the concentrations of 100 
and 200 mg/mL S. cerevisiae extract, C. acnes had no inhibi-
tion zone, whereas the other bacteria show mean zones of 
inhibition in the range from 8.5 to 10.0 mm. The inhibition 
zones of the extract at 100 and 200 mg/mL were significantly 
different from those of the positive control (gentamycin 
10 µg; p<0.05) for all the tested bacteria except for C. acnes. 
Moreover, the inhibition zones of the extract at 100 and 200 
mg/mL were significantly different from that at 300 and 400 
mg/mL for S. aureus and S. epidermidis (p<0.05). Based on the 
mean value of the zones of inhibition, the antibacterial activ-
ity of the S. cerevisiae extract was concentration-dependent. 
Al-Jassani et al. (15) found the inhibition zones of S. cerevisiae 
extract at the volume of 90 μL to be 5.33 and 5.10 mm for S. 
epidermidis and S. aureus, respectively. S. cerevisiae is em-
ployed as a human probiotic and its effects on the host’s 
health include antimicrobial, nutritional, trophic, immuno-
modulatory, anti-inflammatory, quorum sensing, inactivation 
of bacterial toxins, maintenance of epithelial barrier integrity 
and cell restitution (40). Moderate antimicrobial activity of S. 
cerevisiae against bacteria and fungi has been documented; 
furthermore, better antimicrobial activity of cell lysate than 
of whole-cell and culture supernatant has been shown. 
Again, the isolate showed better antibacterial activity against 
Gram-negative than Gram-positive bacteria (41). Additionally, 
S. cerevisiae appeared to have bacterial activity against Pseu-
domonas sp., Salmonella sp., E. coli, Vibrio cholera and Staphy-
lococcus aureus (42). Chen et al. (43) evaluated the antimicro-
bial activity of S. cerevisiae through the inhibition of the 
growth of pathogenic E. coli O8 (MIC=0.025 g/mL), as well as 
its influence on the characteristics of its cell surface. C. inter-
media, C. kefyr and C. lusitaniae exhibited high antimicrobial 
activity against E. coli, while C. tropicalis, C. lusitaniae and S. 
cerevisiae showed moderate antimicrobial activity against E. 
coli. However, all the tested yeasts demonstrated a very low 
activity against  P. aeruginosa (44). Benzeneethanol,4- 
hydroxy- is one of the identified metabolites of S. cerevisiae 
that possess antibacterial activity against human pathogenic 
bacteria. 1-Methyl-3,3-diphenylurea and 1H-indole-3-etha-
nol have also been reported to possess antimicrobial, cardi-
oprotective and anticarcinogenic properties. Diethyldithio-
phosphinic acid, known as O,O-diethyl dithiophosphate, has 
been shown to inhibit the growth of E. coli, S. aureus and Asper-
gillus fumigatus (45). The 9-hexadecenoic acid, present in J. 
curcas leaf extracts, has been shown to possess antimicrobial 





100 200 300 400
S. aureus 9.5±2.1 10.0±1.4 11.0±1.4 11.5±2.1 18.7±0.6
S. epidermidis 8.5±0.7 8.5±0.7 10.0±0.0 10.5±0.7 22.3±0.6
C. acnes 0.0 0.0 9.0±0.0 9.3±0.6 12.0±0.0
Values are expressed as mean±SEM. Analysis was performed with one-way ANOVA, where p<0.05
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properties (46). Many fatty acids, such as hexadecanoic and 
octadecanoic acid, have been documented to show antibac-
terial and antifungal activities (47,48). Pyrrolo[1,2-a]pyra-
zine-1,4-dione,hexahydro isolated from a marine bacteri-
um Bacillus tequil ensis exhibited a potent inhibitory effect 
against multidrug-resistant S. aureus (MIC=15±0.172) mg/L 
and (MBC=20± 0.072) mg/L (35). Furthermore, pyrrolo[1,2-a]
pyrazine-1,4-dione,hexahydro-3-(phenylmethyl)- (PPDHP) 
extracted from Streptomyces sp. has reported antifungal ac-
tivity (49). 
Minimum inhibitory concentration of S. cerevisiae extract
The MIC of S. cerevisiae extract was determined using a 
colorimetric method in which the clear-cut end-points were 
determined via a colour change. Visual detection of bacterial 
growth via turbidity or pellet formation in the wells may be 
difficult and could lead to inaccurate results (50). To detect 
the presence of bacterial growth, p-iodonitrophenyltetrazoli-
um violet was used as an indicator. When there is active bac-
terial growth, colour changes from light yellow to pink or vi-
olet (Fig. S2). The MIC of the extracted metabolites was 18.75, 
31.25 and 75 mg/mL against S. aureus, S. epidermidis and C. 
acnes, respectively. This showed the potential of developing 
these metabolites into compounds with promising bioactiv-
ities against pathogenic microorganisms (Fig. 2). The ob-
tained MIC of the extract against S. aureus showed consisten-
cy at 18.75 mg/mL in the triplicate tests. The mean MIC for S. 
aureus was the lowest among the three bacterial isolates, 
which indicates that the secondary metabolites of S. cerevisi-
ae extract showed better antibacterial activity against S. au-
reus than the other two bacteria. C. acnes showed the highest 
level of resistance against both gentamycin and the tested 
secondary metabolites of S. cerevisiae. 
metabolites extracted from S. cerevisiae had good antimicro-
bial activity against the tested pathogens. The antibacterial 
activity of S. cerevisiae may be attributed to the various phy-
tochemical constituents present in the extract. The individu-
al compounds responsible for this property can be used in 
cosmetic industry. 
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